Cite

    Iaccarino, L. et al. (2018). Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study. Journal of autoimmunity. pp. 1-8. [Online].